BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 37830387)

  • 1. Haematopoietic cell-derived exosomes in cancer development and therapeutics: From basic science to clinical practice.
    Lin WC; Lin YT; Chao HC; Lin YY; Hwang WL
    Clin Transl Med; 2023 Oct; 13(10):e1448. PubMed ID: 37830387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer associated-fibroblast-derived exosomes in cancer progression.
    Li C; Teixeira AF; Zhu HJ; Ten Dijke P
    Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Theranostics Trademark of Exosome in Glioblastoma Metastasis.
    Nag S; Bhattacharya B; Dutta S; Mandal D; Mukherjee S; Anand K; Eswaramoorthy R; Thorat N; Jha SK; Gorai S
    ACS Biomater Sci Eng; 2023 Sep; 9(9):5205-5221. PubMed ID: 37578350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revolutionizing anti-tumor therapy: unleashing the potential of B cell-derived exosomes.
    Xiong J; Chi H; Yang G; Zhao S; Zhang J; Tran LJ; Xia Z; Yang F; Tian G
    Front Immunol; 2023; 14():1188760. PubMed ID: 37342327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein cargo in extracellular vesicles as the key mediator in the progression of cancer.
    Hánělová K; Raudenská M; Masařík M; Balvan J
    Cell Commun Signal; 2024 Jan; 22(1):25. PubMed ID: 38200509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes: Critical Mediators of Tumour Microenvironment Reprogramming.
    Malla RR; Shailender G; Kamal MA
    Curr Med Chem; 2021; 28(39):8182-8202. PubMed ID: 33334279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction.
    Jena BC; Mandal M
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188488. PubMed ID: 33271308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-mediated remodeling of the tumor microenvironment: From local to distant intercellular communication.
    Huang Y; Kanada M; Ye J; Deng Y; He Q; Lei Z; Chen Y; Li Y; Qin P; Zhang J; Wei J
    Cancer Lett; 2022 Sep; 543():215796. PubMed ID: 35728740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.
    Cheng YQ; Wang SB; Liu JH; Jin L; Liu Y; Li CY; Su YR; Liu YR; Sang X; Wan Q; Liu C; Yang L; Wang ZC
    Cell Prolif; 2020 Aug; 53(8):e12865. PubMed ID: 32588948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
    Sundararajan V; Sarkar FH; Ramasamy TS
    Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
    Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
    Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.
    Wu Q; Zhou L; Lv D; Zhu X; Tang H
    J Hematol Oncol; 2019 May; 12(1):53. PubMed ID: 31142326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes in the tumor microenvironment of sarcoma: from biological functions to clinical applications.
    Ye H; Hu X; Wen Y; Tu C; Hornicek F; Duan Z; Min L
    J Nanobiotechnology; 2022 Sep; 20(1):403. PubMed ID: 36064358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exo-MFA - A 13C metabolic flux analysis framework to dissect tumor microenvironment-secreted exosome contributions towards cancer cell metabolism.
    Achreja A; Zhao H; Yang L; Yun TH; Marini J; Nagrath D
    Metab Eng; 2017 Sep; 43(Pt B):156-172. PubMed ID: 28087332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small extracellular vesicle-mediated bidirectional crosstalk between neutrophils and tumor cells.
    Rubenich DS; Omizzollo N; Szczepański MJ; Reichert TE; Whiteside TL; Ludwig N; Braganhol E
    Cytokine Growth Factor Rev; 2021 Oct; 61():16-26. PubMed ID: 34479816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes as a modulator of immune resistance in human cancers.
    Li L; Wang C; Li Q; Guan Y; Zhang X; Kong F; Feng Z; Lu Y; Wang D; Wang N
    Cytokine Growth Factor Rev; 2023 Oct; 73():135-149. PubMed ID: 37543438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal miRNAs in the microenvironment of pancreatic cancer.
    Zou X; Huang Z; Guan C; Shi W; Gao J; Wang J; Cui Y; Wang M; Xu Y; Zhong X
    Clin Chim Acta; 2023 Apr; 544():117360. PubMed ID: 37086943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How cancer cells dictate their microenvironment: present roles of extracellular vesicles.
    Naito Y; Yoshioka Y; Yamamoto Y; Ochiya T
    Cell Mol Life Sci; 2017 Feb; 74(4):697-713. PubMed ID: 27582126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocyte Derived Exosomes: Insight into the Potential Chemo-immunotherapeutic Nanocarrier Targeting the Tumor Microenvironment.
    Basak M; Chaudhary DK; Takahashi RU; Yamamoto Y; Tiwari S; Tahara H; Mittal A
    ACS Biomater Sci Eng; 2023 Jan; 9(1):20-39. PubMed ID: 36524837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles remodel tumor environment for cancer immunotherapy.
    Yue M; Hu S; Sun H; Tuo B; Jia B; Chen C; Wang W; Liu J; Liu Y; Sun Z; Hu J
    Mol Cancer; 2023 Dec; 22(1):203. PubMed ID: 38087360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.